About Aarti Pharmalabs Ltd
Aarti Pharmalabs The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.
Founded
2019
CEO
Rashesh C Gogri
Employees
3,005
HQ
Mumbai, India
Finished Products
1Sale of Manufactured Products
₹3,148.14Cr2Export incentives
₹56.96Cr3Sale of Traded Products
₹42.20Cr4S
₹13.13Cr5Sales of Services
₹9.28Cr6Sale of Scrap
₹3.77CrRaw Materials
1Cost of Material Consumed
₹1,565.55Cr2Purchase of Traded Goods
₹41.19CrAbout Aarti Pharmalabs Ltd
Aarti Pharmalabs The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.
Founded:2019
CEO:Rashesh C Gogri
Employees:3,005
HQ:Mumbai, India
Finished Products
1Sale of Manufactured Products
₹3,148.14Cr2Export incentives
₹56.96Cr3Sale of Traded Products
₹42.20Cr4S
₹13.13Cr5Sales of Services
₹9.28Cr6Sale of Scrap
₹3.77CrRaw Materials
1Cost of Material Consumed
₹1,565.55Cr2Purchase of Traded Goods
₹41.19CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹946
52W Low
₹585
Volume343.72K
Avg VolumeN/A
Beta1.14
Dividend Yield0.40%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
36.91x
Valuation
P/B Ratio
3.70x
Valuation
EPS
₹23.51
Valuation
Dividend Yield
0.40%
Valuation
ROE
8.22%
Profitability
ROCE
9.59%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmacuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
41.6%
International
58.4%
Outside India58.4%
Within India41.6%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.36x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
2.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.